April 16th 2025
The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.
AJMC Study Finds CMS Fee Schedule Doesn't Pay Doctors Enough to Care for Complex Patients
November 27th 2014The call for value-based care is propelled by the shortage of family physicians and the disparity connection between the time it takes to care for the sickest patients and what Medicare and Medicaid pay. A study in this month's issue of The American Journal of Managed Care tracks just how bad things are, by looking at a normal day in a family practice.
Read More
CMS' New Chief Data Officer Part of Transparency Fix
November 25th 2014Amid last week's news that CMS had miscalculated the number of enrollees under the Affordable Care Act was a quieter announcement that the agency had appointed a chief data office to improve transparency, among other tasks.
Read More
Variation in Hospital Inpatient Prices Across Small Geographic Areas
Greater geographic variation was found among private than public payers in the inpatient price per discharge for most hospital services.
Read More
CMS Healthcare Cost Transparency Tools Found Lacking
November 19th 2014In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers. But just how effective are these tools?
Read More
ASCO Members Take a Stand on Access to Care for Low-Income Individuals
November 18th 2014In a paper published in the Journal of Clinical Oncology, medical oncologists have delineated their recommendations to improve cancer care and provide better access to quality care for those patients with financial issues and on Medicaid.
Read More
Managed Care Audience Hears ASCO's Peter Yu, MD, Describe Value-Based Efforts
November 14th 2014Peter Yu, MD, president of the American Society of Clinical Oncology, (ASCO) discussed the organization's efforts throughout 2014 to reform reimbursement and take on issues of value and quality in cancer care during Patient-Centered Oncology Care, the annual gathering sponsored by The American Journal of Managed Care.
Read More
Will Diabetes Get Its Due in Lame Duck Session of Congress?
November 12th 2014Diabetes advocates are pressing for a bill that would compel Medicare to cover CGM technology. They cite a study in The American Journal of Managed Care, which found it costs $17,564 every time a person with diabetes goes to the emergency department with hypoglycemia.
Read More
Predictors of High-Risk Prescribing Among Elderly Medicare Advantage Beneficiaries
This study examines patterns of high-risk prescribing in the elderly Medicare Advantage population and demonstrates that the practice varies widely by geography and drug class.
Read More
Hospice Care Reduces Hospitalizations, Healthcare Expenditures for Medicare Patients
November 11th 2014Hospice care for Medicare patients resulted in lower hospitalization rates and lower healthcare expenditures during the last year of life, according to a study published the November 12 issue of JAMA.
Read More
Fragile, Rural Population to Be Moved Into Medi-Cal Managed Care
November 11th 2014Next month, state health officials will launch a transition of rural Medi-Cal beneficiaries into Medi-Cal managed care health plans. The transition involves about 20,000 of the most frail and elderly segment of the rural Medi-Cal population.
Read More
HCV Care: Access and Cost of Treatment
November 10th 2014The efficacy of oral antivirals for hepatitis C infection is a moot point. The prevailing discussion now delves into the best combinations that can target different viral genotypes, access to these combination regimens, and the subsequent dent in the budget of the patient, the health plan, or the care provider-as the case may be.
Read More
The Global Economics of New HCV Treatments
November 10th 2014Medicare costs, Department of Veterans Affairs budgetary costs, and the economic impact on the developing world-these were some of the topics discussed at the evening session, Health Economics and Cost-Effectiveness, on the third day at The Liver Meeting 2014, held in Boston, Massachusetts, November 7 to 11, 2014.
Read More
Test Predicts Benefit of Extended Endocrine Therapy in Breast Cancer Patients
November 2nd 2014bioTheranostics, Inc's Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be covered by Medicare.
Read More